Varian Grows Cancer Portfolio With Endocare & Alicon Acquisitions

Varian is expanding its cancer care solutions portfolio with two new acquisitions in the interventional oncology space. The medtech giant said it will pay $185m to buy Endocare Systems, based in Austin, Texas; and Alicon, based in Hangzhou, China.

Merging Business Network-Business leaders in global agreement

Varian Medical Systems Inc. will pay $185m to acquire interventional oncology companies Endocare and Alicon. The acquisitions are part of Varian's plans to become a global leader in integrated cancer care solutions, the company said.

Austin, Texas-based Endocare provides hardware and software for cryoablation therapy. The company's lead product, Cryocare CS System, is a fully integrated planning, placement, and treatment delivery system designed to simplify...

More from Oncology

More from Device Area